PRICE T ROWE ASSOCIATES INC /MD/
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 80255
BALTIMORE, MD
Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$62,710,044
-$44,324,519 QoQ
Shares Held
3,206,035
-6.8% QoQ
Ownership
3.11%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. VRDN ranks #49 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in VRDN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62,710,044 | 3,206,035 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $107,034,563 | 3,439,414 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $52,182,684 | 2,418,104 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $40,475,804 | 2,895,265 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $22,755,978 | 1,688,129 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $25,434,966 | 1,326,811 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,024,023 | 45,012 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $577,891 | 44,419 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $549,271 | 31,369 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $564,973 | 25,940 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $406,893 | 26,525 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $569,651 | 23,945 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $576,444 | 22,659 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $727,153 | 24,894 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $360,032 | 17,554 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||